comparemela.com

Latest Breaking News On - Christian pflaumer - Page 1 : comparemela.com

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis

/PRNewswire/ Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for.

United statesChristian pflaumerPeter maagNational institutes of healthKyverna therapeutics incDrug administrationKyverna therapeuticsNational institutesMedia contactNature medicine

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced it.

United statesPeter maagChristian pflaumerKyverna therapeutics incDrug administrationNational institutes of healthTrack designationPatients with refractory myastheniaKyverna therapeuticsNational institutesMedia contactNature medicine

Kyverna Therapeutics Announces Achievement of 28-Day Post-Infusion Milestone for First U S Patient Dosed in Phase 1 Clinical Trial of CD19 CAR T-Cell Therapy for Lupus Nephritis

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company with the mission of engineering a new class of therapies for serious.

United statesSan diegoPeter maagChristian pflaumerUniversity of colorado anschutz medical campusNational institutes of healthColorado anschutz medicalAssociate professorColorado anschutz medical campusLupus nephritisNational institutesNature reviews rheumatologyChronic kidneyNature medicineKyverna therapeutics

Kyverna Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), announced today its participation in the Morgan Stanley 21st Annual Global Healthcare Conference to be held.

New yorkUnited statesPeter maagChristian pflaumerMorgan stanleyAnnual global healthcare conferenceKyverna therapeutics

Verily and Kyverna Therapeutics Announce Collaboration to Advance Cell Therapy for Autoimmune Diseases

/PRNewswire/ Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company.

Amy abernethyJames chungPeter maagCharlie kimSteven cooperChristian pflaumerNational institutes of healthImmune profilerKyverna therapeuticsChimeric antigen receptorNational institutesNature medicine

vimarsana © 2020. All Rights Reserved.